Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14468
Articles
Company
Drug
Boehringer Ingelheim’s Vitiligo Drug EI-001 Approved for Clinical Trials by NMPA
November 14, 2024
Company
Deals
Pharmaron Beijing to Establish Singapore JV Rxilient Biohub for CDMO Services
November 14, 2024
Company
Drug
Haisco Pharmaceutical’s HSK21542 Accepted for NMPA Review in Postoperative Pain Management
November 14, 2024
Policy / Regulatory
NMPA Issues Guidelines for Temporary Import of Urgently Needed Medical Devices
November 14, 2024
Company
Abbott Reports 8.7% Drop in Q3 2023 Global Sales, Hit by Lower SARS-CoV-2 Test Demand
November 14, 2024
Company
Drug
Roche’s Alecensa Shows Unprecedented 76% Improvement in Disease-Free Survival in NSCLC Trial
November 14, 2024
Company
Deals
Eli Lilly Acquires Mablink Bioscience to Expand Next-Gen ADC Portfolio
November 14, 2024
Company
Deals
Belief BioMed Partners with Takeda for BBM-H901 Commercialization in Asia
November 15, 2024
Company
Drug
MicuRx Pharmaceuticals Initiates Phase I Study for MRX-5 in Australia
November 14, 2024
Company
Drug
GenScript Reports $152 Million in Sales for Carvykti as of September 30, 2023
November 14, 2024
Company
Drug
Novartis Launches Leqvio in China at RMB 9,988 per Shot
November 14, 2024
Company
Drug
Zhejiang Huahai Pharmaceutical Secures Orphan Drug Designation for HB0034
November 14, 2024
1
2
…
859
860
861
862
863
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?